AnalystsJeet MukherjeeJeet Mukherjee's Stock Forecasts
AnalystsJeet Mukherjee
Sectors:
Industries:
Analyst Ranking
Top 32%
#1623 out of 5121 analysts
Average Return
+13.34%
Win Rate
62%8 out of 13
Risk vs Reward
Poor
Good
Jeet Mukherjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +69.02% | $44.93 | $75.94 | 2025-09-09 - 2025-12-02 | Strong Buy |
Nurix Therapeutics IncNRIX | +57.21% | $10.40 | $16.35 | 2025-10-23 - 2025-12-02 | Strong Buy |
Arvinas IncARVN | +51.04% | $7.72 | $11.66 | 2025-09-18 - 2025-12-02 | Strong Buy |
Kymera Therapeutics IncKYMR | +42.66% | $45.05 | $64.27 | 2024-12-10 - 2025-12-02 | Strong Buy |
Monopar TherapeuticsMNPR | +39.37% | $54.49 | $75.94 | 2025-09-15 - 2025-12-02 | Strong Buy |
Jeet Mukherjee Analyst Color
Get additional color on Jeet Mukherjee's coverage of popular stocks
Jeet Mukherjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aardvark Therapeutics IncAARD | 1 | Strong Buy | $26.00 | +180.78% | Initiates Coverage On | a month ago |
Nurix Therapeutics IncNRIX | 3 | Strong Buy | $27.00 | +65.14% | Reiterates | a month ago |
Arvinas IncARVN | 2 | Strong Buy | $14.00 | +20.07% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $75.00 | +16.70% | Maintains | a month ago |
Perspective Therapeutics IncCATX | 2 | Strong Buy | $14.00 | +582.93% | Reiterates | 2 months ago |
Monopar TherapeuticsMNPR | 3 | Strong Buy | $104.00 | +36.95% | Maintains | 2 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.